CorMedix CRMD U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards
U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's u.s. federal, state and foreign net operating loss, credit carryforwards and other carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards?
- CorMedix (CRMD) reported U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards of $117.14M in Q4 2025.
- How has CorMedix's U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards changed year-over-year?
- CorMedix's U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards increased by 110.0% year-over-year, from $55.78M to $117.14M.
- What is the long-term trend for CorMedix's U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards?
- Over 5 years (2020 to 2025), CorMedix's U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards has grown at a 24.6% compound annual growth rate (CAGR), from $38.99M to $117.14M.